Clinical application of polylactic acid/gelatin nanofibre membrane in hard-to-heal lower extremity venous ulcers

J Wound Care. 2022 Nov 2;31(11):930-940. doi: 10.12968/jowc.2022.31.11.930.

Abstract

Objective: To evaluate the safety and effectiveness of polylactic acid/gelatin nanofibre membranes (PGNMs) in treating hard-to-heal lower extremity venous ulcer wounds.

Method: In this prospective study, patients with venous leg ulcers (VLUs) were treated with PGNMs or standard of care. Wounds were assessed once a week until the wound was fully healed.

Results: The treatment group was comprised of 10 patients with VLUs, aged between 47-64 years, with an average age of 56.58±6.19 years. The wounds were located in the lower leg and/or ankle. Average wound area was 8.91±13.57cm2 (range: 1.5-52.5cm2). Average wound healing time was 18.75±16.36 days. Of the patients, nine (90%) rated their pain as lighter when removing the dressing, with an average pain value of 2.0±1.0 points. There was less secondary trauma to the wound surface, and less bleeding. At six months after the wound healing, the scar evaluation (using the Vancouver Scar Scale) result was 3.75±1.96 points.

Conclusion: In this study, the PGNMs were safe and effective in treating hard-to-heal lower extremity VLUs.

Keywords: chronic; gelatin; hard-to-heal; lower extremity; membranes; nanofibre; polylactic acid; ulcer; varicose veins; venous ulcer; wound; wound care; wound dressing; wound healing.

MeSH terms

  • Cicatrix
  • Gelatin / therapeutic use
  • Humans
  • Lower Extremity
  • Middle Aged
  • Nanofibers*
  • Pain
  • Prospective Studies
  • Varicose Ulcer* / therapy
  • Wound Healing

Substances

  • Gelatin
  • poly(lactide)